Global Interventional Oncology Market to be worth $1,506.3 Million by 2025 | Industry Size, Share, Growth, Forecast and Opportunities during Forecast period

Meticulous Research®– leading global market research company published a research report titled “Interventional oncology Market by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))], Product [Embolization (SIR-Spheres, TheraSpheres)], Application (Liver, Lung, Breast), and End User– Global Forecast to 2025”. According to this latest publication from Meticulous Research®, the global interventional oncology market is expected to grow at a CAGR of 7.7% from 2019 to reach $1,506.3 million by 2025. The high growth of interventional oncology market is mainly attributed to growing preference for minimally invasive treatment procedures, increasing incidence of cancer, rising number of hospitals, and technological advancements in the field of radiology. However, high cost and risks associated with the interventional oncology procedures and paucity of skilled healthcare professionals are the key factors expected to hinder the adoption of interventional oncology procedures.

Request Sample Report Now: https://www.meticulousresearch.com/request-sample-report/cp_id=4951

Future looks bright for interventional oncology

The global interventional oncology market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2025-by procedure (embolization [TARE, TACE], ablation thermal ablation [microwave, RF ablation]), by product (embolization [SIR-spheres, theraspheres], ablation), application (liver, lung, breast), end user (hospitals, ambulatory care center), and geography. The study also evaluates industry competitors and analyzes the market at regional and country level.

Key questions answered in the report-

 •  Which are the high growth market segments in terms of products, procedures, applications, end users, and region/countries?

 •  What was the historical market for interventional oncology across the globe?

 •  What are the market forecasts and estimates for the period 2019-2025?

 •  What are the major drivers, restraints, opportunities, and trends in the global interventional oncology market?

 •  Who are the major players in the global interventional oncology market?

 •  How is the competitive landscape and who are the market leaders in the global interventional oncology market?

 •  What are the recent developments in the global interventional oncology market?

 •  What are the different strategies adopted by the major players in the global interventional oncology market?

 •  What are the geographical trends and high growth regions/ countries?

Have Any Query? Ask Our Experts Here: https://www.meticulousresearch.com/speak-to-analyst/cp_id=4951

On the basis of procedure, the embolization procedure segment accounted for the largest share of this market in 2018. The large share of this segment is mainly attributed to better clinical outcomes, high specificity towards tumor cells, and continuous advancements in embolization procedures and associated agents. In embolization segment, trans arterial radioembolization accounted for the largest share and is projected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to successful clinical outcomes and high efficiency due to localized radiation treatment & use of radioactive isotopes such as yttrium Y-90 in the procedure.

The interventional oncology procedures, on the basis of products are majorly classified into tumor embolization (radioactive embolic agents/radioembolic agents and non-radioactive embolic agents) and tumor ablation (generators and consumables & accessories). Due to localized & directed radiation and favorable reimbursement scenario for radioembolization procedures, radioactive embolic agents segment commanded the largest share of the global interventional oncology market in 2018. The key factors driving the growth of this market include the increasing accessibility to the embolization products, rising coverage of the product for reimbursement across the globe, and increasing incidence of cancer & related mortality.

On the basis of application, liver cancer accounted for the largest share of the global interventional oncology market in 2018. The major share of this segment is primarily attributed to the availability of wide range of embolization and ablation products globally for liver cancer treatment and growing prevalence of the disease and related mortality. Furthermore, this segment is also estimated to grow at the highest CAGR during the forecast period with rising diagnosis and treatment rate of the disease with growing awareness about the fatality and benefits of early diagnosis and treatment across the globe, and growing access to innovative products and their increasing coverage for reimbursement.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/Interventional-Oncology-Market-4951/

The hospitals segment accounted for the largest share in 2018. This is primarily attributed to large volume of interventional oncology procedures performed in hospitals. On the other hand, ambulatory care centers are expected to grow at the highest CAGR in the forecast period due to provision of cost-effective treatment procedures.

This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America, and Middle East & Africa. North America commanded the largest share of the global interventional oncology market in 2018, followed by Europe and Asia Pacific. However, Asia Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in this market is expected to be driven by large pool of cancer patients; growing government focus on healthcare sector; increasing health insurance penetration; and increasing disposable income of the population that improved the access to diagnosis and treatment. In addition, favorable government policies and healthcare structural reforms are further expected to drive the market growth.

The key players operating in the global interventional oncology market are Boston Scientific Corporation, C. R. Bard, Inc., Medtronic plc, Cook Medical LLC, Merit Medical Systems, Inc., Profound Medical Corp, AngioDynamics, Inc., BTG plc, Terumo Corporation, HealthTronics, Inc., EDAP TMS S.A., Neuwave Medical, Inc., Sirtex Medical Limited, Trod Medical, Teleflex Incorporated, Sanarus Technologies Inc., IMBiotechnologies Ltd., MedWaves, Inc., and IceCure Medical Ltd.

Download Free Sample Report Now: https://www.meticulousresearch.com/download-sample-report/cp_id=4951

Key Findings in the Global Interventional Oncology Market Study:

Tumor embolization procedures to witness the largest demand through 2025

Tumor embolization procedures commanded the largest share of the global interventional oncology market in 2018 mainly due to their wide usage with high sensitivity, specificity, and accuracy towards detection and characterization of tumors. In addition, the advancements in embolization procedures along with research programs for the improvement of yttrium 90 isotopes efficiency, has led to the increase in demand for embolization procedures worldwide.

Liver cancer to dominate the interventional oncology market by 2025

Liver cancer commanded the largest share of the global interventional oncology in 2018 primarily due to the availability of wide range of embolization and ablation products globally for liver cancer treatment and growing prevalence of the disease and related mortality. Furthermore, this segment is also estimated to grow at the highest CAGR of 8.0% during the forecast period with rising diagnosis and treatment rate of the disease with growing awareness about the fatality and benefits of early diagnosis and treatment across the globe, and growing access to innovative products and their increasing coverage for reimbursement.

Hospitals to dominate the global interventional oncology market

Hospitals commanded the largest share of the global interventional oncology market in 2018. Rising number of private hospitals in the emerging countries coupled with the large pool of cancer patient population visiting hospitals for diagnosis & treatment is driving the growth of this market. For instance, according to the Commonwealth Fund, the total number of hospitals in China has increased significantly over the last decade from roughly 18,700 in 2005 to ~27,600 hospitals in 2015 and ~31,056 in 2017. In addition to the above factors, rising reimbursement for interventional oncology procedures, improving healthcare infrastructure, and accessibility to hospitals globally are the key factors further supporting the growth of interventional oncology market in hospitals.

Visit Top 10 Companies in Interventional Oncology Market: https://meticulousblog.org/top-10-companies-in-interventional-oncology-market/

Related Reports:

1. Radiotherapy Market by Product (Radiotherapy Devices, Software, Service), Procedure (EBRT, Brachytherapy, Systemic Radiotherapy), Technology (IMRT, SRT, VMAT, HDRBT, LDRBT, PDRBT), Application (Prostate, Breast) – Global Forecasts to 2025

2. North America Quality Management In Healthcare Market By Software (BI, Analytics, Reporting, Performance Improvements), Mode Of Delivery (Cloud, Web, On-Premise), Application (Data, Risk Management) And End User (Hospital, Ambulatory Care, Payer) – Forecast To 2024

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- https://twitter.com/MeticulousR123

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at contact@wiredrelease.com.